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Abstract The icosahedral nucleocapsid of hepatitis B virus
(HBV) consists of multiple subunits of a single 183 amino acids
(aa) core protein encasing the viral genome. However, recombi-
nant core protein alone also forms capsid-like particles. We have
recently shown that a 238 aa protein centrally inserted into the
core protein can be displayed on the particle surface. Here we
demonstrate that replacement of the C-terminal basic domain by
the 17 kDa Staphylococcus aureus nuclease also yields particles
but that in these the foreign domains are located in the interior.
The packaged nuclease is enzymatically active, and the chimeric
protein forms mosaic particles with the wild-type core protein.
Hence the HBV capsid is useful as a molecular platform which,
dependent on the fusion site, allows foreign protein domains to
either be packaged into or be exposed on the exterior of the
particle. These results are of relevance for the use of the HBV
capsid as a vaccine carrier, and as a target for antiviral
therapy. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Hepatitis B virus (HBV), the causative agent of B-type hep-
atitis in humans [1], is an enveloped DNA-containing virus
that replicates through reverse transcription (for reviews: [2^
4]). Virion morphogenesis starts with encapsidation by the
capsid, or core, protein of a complex consisting of one of
the viral RNAs, the reverse transcriptase, and probably cellu-
lar chaperones [5]. After reverse transcription, the DNA-con-
taining nucleocapsid buds into a pre-Golgi compartment, ex-
iting from the cell as enveloped virion [6].
Whereas formation of authentic nucleocapsids is thus a
complex process, the 183 amino acids (aa) core protein by
itself is able to form capsid-like particles upon heterologous
expression. Such systems allowed for the biochemical and bio-
physical characterization of the core protein. The N-terminal
144 aa form the actual assembly domain [7] while the basic C-
terminus is required for nucleic acid binding (Fig. 1A). Elec-
tron cryo microscopy (cryo EM) revealed two forms of the
icosahedrally symmetric capsid [8,9] : the smaller particles (tri-
angulation number T = 3) contain 180, the larger ones (T = 4)
240 subunits. The actual building blocks are core protein
dimers which adopt a hammer-like structure (Fig. 1A, right).
The heads form the capsid shell while the shafts protrude
from the surface as spikes. From higher resolution studies
[10,11], a model for the fold of the assembly domain was
proposed (Fig. 1B, left) which predicted four helices [10].
The two long central helices would be involved in dimeriza-
tion by forming a four-helix bundle with their counterparts in
a second subunit. This model was corroborated biochemically
[12,13], and ¢nally con¢rmed in further detail by the recently
solved 3.5 Aî X-ray structure [14]. The structure of the basic
C-terminus is not known but, as expected from its nucleic acid
binding function, it is located in the particle interior [10,15].
Because of its fundamental role in the viral life-cycle, the
HBV capsid is a potential target for antiviral therapy (for
review: [16]) ; it is also of interest as a particulate carrier for
foreign epitopes that may be suitable as vaccines (for reviews:
[17,18]). Various heterologous sequences have been inserted
into the core protein with the aim of maintaining the partic-
ulate structure while at the same time exposing the foreign
sequence on the surface. Additions to the termini of the
core protein, in particular to the C-terminus, did frequently
not interfere with particle assembly but the immunogenicity of
the foreign part was rather low, suggesting it was not well
accessible. By contrast, insertions into the central immuno-
dominant c/e1 epitope region around aa 80 (Fig. 1B) at the
tips of the surface spikes [19] were often highly immunogenic
but the assembly-competence of such variants appeared to be
restricted to relatively short to medium-sized [20] inserts.
However, we have recently demonstrated that insertion of
the entire green £uorescent protein (GFP) into this site yields
particles that display GFP on their surface [21]. Here we
asked whether, by appropriate design, the HBV capsid could
also be used to package multiple copies of a substantially
sized protein into its interior. As a model, we used the nucle-
ase (Fig. 1C) of Staphylococcus aureus (SN), a globular 17
kDa protein [22] that degrades DNA and RNA in a Ca2-
dependent fashion [23]. Below we show that a chimeric pro-
tein containing the entire SN protein fused to the C-terminus
of the core protein’s assembly domain indeed meets these
criteria.
2. Materials and methods
2.1. Plasmid constructs
The parental construct for HBV core protein expression, plasmid
pPLC4-1 [24], contains a synthetic core gene under control of the
phage lambda pL promoter. Using plasmid pTSN2cc (kindly provided
by J. Markley) as template and appropriate oligonucleotide primers, a
PCR product encoding the nuclease A part of SN (V8 strain contain-
ing the H124L mutation), preceded by 6 aa from the authentic pro-
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peptide and followed by a C-terminal His6 tag, was obtained. This
fragment was cloned by standard procedures between the BstEII (po-
sition 461) and HindIII (position 555) of pPLC4-1, yielding plasmid
pPLC-SNwt. The encoded protein, coreSNwt, consists of HBV core
protein aa 1^155, a two aa linker, and tagged SN as described above.
Fusions with enzymatically disabled SN domains [25,26], coreSN-
mut87 and coreSNmut43/87, were obtained by introduction into SN
of aa exchanges R87G alone (plasmid pPLC-SNmut87), or in combi-
nation with E43S (plasmid pPLC-SNmut43/87). For co-expression,
plasmid pDM/c1^183 (M. Nassal and A. Frank, unpublished data)
was used which encodes wild-type HBV core protein c1^183 under
control of the bacteriophage T7 A1 promoter coupled to two lac
operators; this A1/O4/O3 promoter, as present in the pUHE plasmids
derived from the pDS series [27], is inducible by IPTG. The plasmid
carries the lacIq allele of the lac repressor, the P15A replication origin
from pACYC184, and confers resistance to kanamycin. Hence both
plasmids can be maintained in the same cell, and protein expression
can be separately induced.
2.2. Expression of variant and wild-type HBV core proteins
Expression experiments were performed in Escherichia coli GI698
cells (Invitrogen) by tryptophan induction (100 Wg/ml) as previously
described [12]. In co-expression experiments, transcription from plas-
mid pDM/c1^183 was induced by addition of IPTG (¢nal concentra-
tion 1 mM). Usually, bacterial cultures were grown at 30‡C to mid-log
phase (about 0.5 OD 550 nm), then inductor was added and the
cultures were maintained at 23‡C for about 16 h.
2.3. Puri¢cation of recombinant proteins
Induced bacterial cultures were lysed by lysozyme/detergent treat-
ment and sonication as previously described [12]. Core protein deriv-
atives were precipitated using 40% saturated ammonium sulphate,
redissolved in phosphate-bu¡ered saline (PBS) bu¡er (10 mM
Na2HPO4, 2 mM NaH2PO4, 140 mM NaCl), and after dialysis sub-
jected to sedimentation in sucrose gradients consisting of six layers of
10^60% (w/v) sucrose in PBS. For preparative gradients, each sucrose
layer consisted of 2 ml, and 800 Wl of cleared dialysate was loaded and
centrifuged at 20‡C for 105 min at 41 kRPM in a TST 41.14 rotor
(Kontron). For analytical gradients, each sucrose layer as well as the
sample had a volume of 200 Wl. Centrifugation conditions were 20‡C,
40 min, 55 kRPM in a TLS55 rotor (Beckman). Gradients were frac-
tionated from top to bottom. Protein contents of individual fractions
were analyzed by sodium dodecyl sulphate (SDS)^PAGE (12.5% poly-
acrylamide, 0.1% SDS; [28]) followed by Coomassie blue staining or
Western blotting onto Hybond-P PVDF membranes and chemilumi-
nescence detection (ECL Plus; both Amersham Pharmacia) using ap-
propriate primary and secondary antibodies.
2.4. Native agarose gel electrophoresis of recombinant particles
Aliquots from individual gradient fractions were subjected to elec-
trophoresis in native agarose gels (0.5^1%) as previously described
[7,12,21]. As running bu¡er, TAE (40 mM Tris^acetate pH 8.1, 0.1
mM EDTA) containing 0.5 Wg/ml ethidium bromide was used. Nu-
cleic acids were visualized by illumination at 365 nm. Proteins were
detected directly by Coomassie blue staining, or by immunoblotting
after capillary transfer to PVDF membranes as described above.
2.5. Dissociation of chimeric particles
Equal aliquots from gradient-puri¢ed particle preparations were
dialyzed against either 3 M urea in 25 mM Tris^Cl3 pH 9.5, or
against TN bu¡er (10 mM Tris^Cl3, pH 7.5, 100 mM NaCl) and
resedimented in sucrose gradients made up with the same bu¡ers.
For the nuclease assays described below, proteins from the top frac-
tions (urea-treated) and from the particle-speci¢c lower fractions (TN-
incubated) were used.
2.6. Nuclease activity assays
Nuclease activity was determined by using covalently closed circular
(ccc) plasmid DNA as substrate [25], and monitoring the disappear-
ance of cccDNA and the concomitant generation of open circular (oc)
and linear DNAs by agarose gel electrophoresis (1% agarose, TAE
bu¡er). Reaction mixtures contained, in a total volume of 200 Wl TN
bu¡er, 20 Wg of a 5.3 kb plasmid DNA (5.7 pmol), 10 mM CaCl2 and
approximately 2.5 ng (0.07 pmol) of coreSN protein (obtained by
resedimentation after TN or urea incubation as described above).
Mixtures were incubated at 37‡C. 15 Wl aliquots were removed after
0.5, 1, 2, 3, 4, 5, 10, 20 and 30 min and EDTA was immediately added
to 50 mM to stop the reaction. As control, 1.2 ng per assay (0.07
pmol) of a commercial SN preparation (Amersham Pharmacia USB;
speci¢c activity: 17 U/Wg) was used. To account for possible e¡ects of
urea on nuclease and/or substrate, control assays were performed
using SN that had been incubated for 1 h with 3 M urea in 25 mM
Tris^Cl3 pH 9.5. For quantitation, pictures of the ethidium bromide-
stained gels were taken using a DIANA CCD camera, and cccDNA
band intensities were determined using AIDA software (both Rayt-
est). Curves were ¢t exponentially using Microsoft Excel. Nuclease
activity against packaged RNA was induced by addition to gra-
dient-puri¢ed particles of CaCl2 to a ¢nal concentration of 10 mM.
2.7. Antibodies
For detection of HBV core protein, the following antibodies were
used: H800, a polyclonal rabbit antiserum raised against denatured
c1^149 protein [7]; monoclonal antibodies mc312 [29] and mc275 [30],
recognizing the major c/e1 epitope, and a particle-speci¢c conforma-
tional epitope, respectively. His tags were detected using the tetra-His
monoclonal antibody (Qiagen).
2.8. EM
For negative staining, 2 Wl of a solution containing the gradient-
puri¢ed particles was applied to a carbon-coated copper grid and
Fig. 1. Structures of the HBV core protein and of S. aureus nucle-
ase. A: Primary sequence of the core protein and schematic repre-
sentation of the core protein dimer. The assembly domain extends
from the N-terminus to about aa 144, followed by a basic nucleic
acid binding domain (marked by ++). The black box depicts the
immuno-dominant c/e1 epitope region. Gray shading refers to the
approximate location of the corresponding sequences in the topolog-
ical dimer model (right). Two assembly domains associate into a
hammer-shaped dimer. The c/e1 epitope (black loop) is located at
the tip of the spike. The basic C-termini (++) are directed into the
particle interior. B: Structural model of the core protein. The cylin-
ders represent the major core protein helices; gray shading is as in
A. C: Structure of SN. The RasMol representation is based on a
1.5 Aî X-ray structure of SN [22], and comprises residues 1^141 of
mature nuclease A. Scales in B and C are similar. D: Linear repre-
sentation of the coreSN fusion proteins used in this study. The core
protein part encompasses the sequence 1^155 to which mature SN
1^149, preceded by 6 aa from the authentic propeptide and followed
by a His6 tag, is joined via a 2 aa linker. Two variants with essen-
tially inactive SN domains contain the mutations R87G, and
E43S+R87G.
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incubated for approximately 1 min. The grid was washed twice with
water and twice with 2% uranyl acetate and ¢nally stained for 1 min
with 2% uranyl acetate. Micrographs were taken on a Philips EM 400
operating at 100 kV at a nominal magni¢cation of 55 000. For cryo
EM, aliquots from appropriate sucrose gradient fractions were dia-
lyzed against PBS bu¡er, then concentrated to about 2^5 mg/ml pro-
tein using a Centricon 500 microconcentrator (Millipore). Sample
preparation and microscopy were carried out as described [10] using
a Hitachi HF2000 equipped with a Gatan cold stage. The temperature
of the stage was maintained between 97 and 100 K. Micrographs were
taken under low dose conditions at a nominal magni¢cation of 60 000
with a 2 s exposure time.
3. Results
3.1. Chimeric coreSN proteins form particles
The structures of the coreSNwt protein and its enzymati-
cally disabled variants serving as controls for nuclease-speci¢c
e¡ects are shown in Fig. 1C. All proteins were expressed in
substantial amounts in E. coli GI698 cells (about 10 mg/l of
bacterial culture), and their identity was con¢rmed by West-
ern blotting with monoclonal antibodies against core protein
and the C-terminal His tag (not shown). As a ¢rst test
whether the chimeric coreSN proteins are able to form par-
ticles, cleared bacterial lysates were sedimented through su-
crose gradients. As shown in Fig. 2 for the coreSNwt fusion,
most of the 36 kDa chimeric protein was present in fractions
that are characteristic for the particulate form; both coreSN-
mut proteins displayed essentially the same sedimentation be-
havior.
An independent method to detect particle formation is na-
tive agarose gel electrophoresis [31]. Stable wild-type HBV
capsids migrate as distinct bands through the gel matrix [7].
However, all coreSN proteins appeared as a relatively broad
smear, with only the leading edge migrating close to the posi-
tion of wild-type core particles. While compatible with the
presence of particles with decreased stability [12], the experi-
ments did not conclusively con¢rm particle formation. How-
ever, the distinct mobility was useful for the detection of mo-
saic particles formed upon co-expression with wild-type core
protein (see below and Fig. 5B).
In order to obtain de¢nite proof for the assembly-compe-
tence of the fusion proteins, we used EM, and compared the
Fig. 2. The chimeric coreSNwt protein is assembly-competent.
Cleared lysate from an induced culture of E. coli cells transformed
with plasmid pPLC-SNwt was centrifuged through a 10^60% su-
crose gradient in PBS bu¡er. Aliquots from individual gradient frac-
tions were analyzed by SDS^PAGE and stained with Coomassie
blue. The bulk of the 36 kDa coreSNwt protein is present in frac-
tions 9^12 characteristic for particles.
Fig. 3. EM of coreSNwt particles. Particles from truncated wild-type core protein c1^149, and from the chimeric proteins coreSNwt and core-
GFP were analyzed by negative staining with uranyl acetate (left panels), or by cryo EM (right panels). Magni¢cation is the same within one
series but di¡ers between the left and right panels. The naturally low contrast of the cryo electron micrographs is due to the low atomic masses
of the constituent elements of proteins. A blow-up of single particles, indicated by the white arrows, is shown at the bottom; left to right order
corresponds to top to bottom in the large pictures.
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material from the particle-speci¢c coreSNwt gradient fractions
with particles formed by the truncated wild-type core protein
c1^149, and with coreGFP particles that expose the GFP
domains on their surface [21]. Negative staining with uranyl
acetate (Fig. 3, left panels) revealed abundant particles in the
coreSNwt preparations, with two distinct features: (i) their
overall size was similar to that of authentic c1^149 capsids
but smaller than that of chimeric coreGFP particles; in
turn, the apparent thickness of the capsid shells was in-
creased; (ii) a substantial fraction of the particles were de-
formed to some degree. The micrographs obtained with the
chimeras containing mutant SN domains were basically iden-
tical (not shown). Di¡erent from negative staining, in cryo
EM, the specimens are observed under quasi-native conditions
(for review: [32]). The diameter of the chimeric particles (Fig.
3, right panels) was again similar to that of wild-type capsids,
but they appeared much more regularly shaped than after
negative staining; as for the c1^149 capsids, there were
much more T = 4 than T = 3 particles. A direct comparison
of single, typical particles observed by either technique is
shown at the bottom of Fig. 3. Hence these data provide
direct evidence for the assembly-competence of the coreSN
protein, and they strongly suggest that the SN domains are
packaged in the lumen of the particles. This was corroborated
by radial density plots (not shown): both coreSN and c1^149
displayed the strongest peaks at a radius of about 143 Aî ,
corresponding to the region of highest capsid shell density,
but only coreSN produced additional density peaks at radii
of around 77 Aî and 108 Aî , i.e. inside the shell ; coreGFP
particles, by contrast, produced an additional outer density
peak at about 186 Aî .
3.2. The SN domain in the chimeric protein is enzymatically
active
To show that the SN domains were correctly folded, and to
obtain independent evidence for their interior location, we
tested the nuclease activity of the coreSNwt protein with
and without subjecting the particles to 3 M urea in 25 mM
Tris^Cl3 pH 9.5, a treatment expected to lead to dissociation
into dimers [33]. This should increase rather than decrease
nuclease activity because the SN domains buried in the par-
ticle would gain access to the substrate. Puri¢ed coreSN and
coreSNmut particles were dialyzed against the above de-
scribed bu¡er and, for control, against TN bu¡er. After re-
sedimentation through sucrose gradients, aliquots from a top
fraction from the dissociated material, and from a particle
fraction of the control preparation containing equal amounts
of fusion protein were used. A commercial preparation of SN
at approximately the same molar concentration served as a
positive control. To account for the potential in£uence of urea
on nuclease activity, the SN used for comparison with the
dissociated coreSN particles was also pretreated with 3 M
urea.
Nuclease activity was assayed using the distinct electropho-
retic mobilities of oc and linear forms of plasmid DNA gen-
erated by nucleolytic attack on cccDNA [25]. Visual inspec-
tion of the gels revealed that the cccDNA was much more
slowly converted into oc and linear DNA by the native core-
SN particles than by native SN (Fig. 4A, left panels). By
contrast, the urea-treated chimera showed a largely increased
activity, exceeding that of urea-treated SN (right panels). Ex-
pectedly, the coreSNmut chimeras displayed no activity (not
shown). For a semi-quantitative evaluation, the bands corre-
sponding to cccDNA were densitometrically scanned, and
their intensities were plotted vs. reaction time (Fig. 4B). Rel-
ative reaction velocities were determined from the slopes be-
tween initial time points. Urea treatment of the coreSNwt
particles increased the initial velocity by about 8.5-fold where-
as that of SN itself dropped about 2.5-fold (from 15-fold to
6-fold faster than with the native coreSNwt particles). Con-
sidering this negative in£uence of urea on SN enzyme activity,
this indicates an about 20-fold increase in the apparent activ-
ity of the chimeric coreSNwt protein after particle dissocia-
tion, consistent with the internal localization of the SN do-
mains. Comparable results were obtained when denatured
herring sperm DNA was used as substrate and the release
of acid-soluble material was measured photometrically (data
not shown).
Fig. 4. Increased nuclease activity of coreSNwt after particle dissoci-
ation. A: Plasmid cccDNA conversion assay. Gradient-puri¢ed core-
SNwt particles were treated with either 3 M urea or with bu¡er,
and resedimented on sucrose gradients. Equal amounts of dissoci-
ated (marked UREA) and of particulate (bu¡er control, marked
NATIVE) protein were incubated with plasmid cccDNA. Urea-
treated and non-treated SN at the same concentration served as
control. Samples were taken at the indicated times and the disap-
pearance of cccDNA (marked ccc) and concomitant generation of
oc and linear DNA (marked oc and lin) were monitored by agarose
gel electrophoresis and ethidium bromide staining. B: Semi-quanti-
tative evaluation of relative reaction rates. The intensities of the
cccDNA bands in each lane were determined densitometrically. The
values, with the intensity at 0 time in each series set to 100%, were
plotted vs. incubation time. Exponential ¢tting was used to derive
the curves shown.
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3.3. Chimeric coreSN proteins co-assemble with wild-type core
protein to form mosaic particles
To test whether the coreSN proteins were able to co-assem-
ble with the wild-type core protein, both were simultaneously
expressed in the same E. coli cells. The expression products
were puri¢ed and analyzed as described above. SDS^PAGE of
sucrose gradient fractions showed that in all cases the 21 kDa
wild-type core protein and the 36 kDa chimera co-sedimented
(Fig. 5A, upper left panel). By contrast, a mixture of prepuri-
¢ed wild-type and chimeric capsids showed a slight but dis-
tinct shift in the peak positions of the two proteins (lower left
panel). Further evidence for the presence of mosaic particles
was obtained by native agarose gel electrophoresis (Fig. 5B).
A mixture of pure wild-type core protein and coreSNwt (lane
1) showed the same di¡erent mobilities as the individual pro-
teins (lanes 4 and 5). By contrast, when coreSNwt was co-
expressed at about equimolar concentration with wild-type
core protein, one broad band was observed that moved closer
to the position of wild-type particles (lane 2), and the material
condensed into a distinct, wild-type-like band when the wild-
type core protein was present in about 3^4-fold excess over
coreSNwt (lane 3). This gradual mobility shift indicated that
mixed particles had formed. This conclusion was corroborated
by negative staining EM which revealed again abundant par-
ticles with a very similar appearance in all preparations (Fig.
5C). They looked much more uniform and regular than those
formed from pure coreSN protein.
3.4. The SN domains inside mosaic particles are enzymatically
active
Particles from full-length wild-type core protein package
substantial amounts of E. coli RNA which can be detected
in situ by native agarose gel electrophoresis in the presence of
ethidium bromide. Particles from the truncated variants lack-
ing the basic C-terminal region, by contrast, contain relatively
little nucleic acid [7]. Chimeric coreSN particles per se are
therefore not expected to carry packaged nucleic acid while
in mixed particles the wild-type protein may bring in detect-
able amounts of RNA. Accordingly, particle preparations
from wild-type core protein, from the chimeric coreSNwt
and coreSNmut87 proteins, and from co-expressions were an-
alyzed side-by-side using the native gel assay (Fig. 6, upper
panel). For an estimate of the protein amounts present in each
lane, the gels were subsequently stained with Coomassie blue
(Fig. 6, lower panel). Since similar amounts of protein were
present in all samples, the intensity of the ethidium bromide
stain is an approximate measure for the relative amounts of
nucleic acid per particle. Expectedly, pure wild-type core par-
Fig. 5. Evidence for mosaic particle formation from coreSNwt and wild-type c1^183 proteins. A: Sedimentation velocity. Co-expressed core-
SNwt plus wild-type c1^183 protein (upper panel) or a mixture of the separately expressed proteins were sedimented through a sucrose gra-
dient. M denotes marker proteins of the indicated sizes, lane 0 is an aliquot of the samples loaded on the gradient. Fractions were analyzed by
SDS^PAGE and stained with Coomassie blue. The co-expressed proteins co-sedimented, whereas the peaks of the two proteins were shifted in
the mixture (arrows). B: Native agarose gel electrophoresis. Aliquots from particle-speci¢c gradient fractions were subjected to electrophoresis
in 0.5% agarose gels, and the proteins were stained with Coomassie blue. On lanes 4 and 5, separately expressed wild-type c1^183 core (wt-
core) and coreSNwt protein were loaded, lane 1 (Mix) contained a mixture of the two. Lanes 2 and 3 are derived from co-expression. The ma-
terial in lane 2 contained about equimolar amounts of both proteins, in lane 3, wild-type core protein was present in an about 4-fold molar ex-
cess. C: EM analysis of mosaic particles. Co-expressed coreSNwt plus wild-type c1^183 particles and individually expressed coreSNwt particles
were analyzed in parallel by negative staining. Note the uniform particle appearance upon co-expression compared to the frequently distorted
and/or incomplete particles (arrows) in the coreSNwt preparation.
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ticles gave a strong signal (lane 1a) whereas no or only a
minimal staining was observed with pure coreSNwt and core-
SNmut (lanes 2a and 3a). The mosaic particles, by contrast,
were clearly stained; this staining was more intense for par-
ticles containing the enzymatically inactive coreSNmut (com-
pare lanes 4a and 5a). Pretreatment with exogenously added
RNase A did not abolish staining (lanes 1b^5b), suggesting
that most of the visible RNA was protected, i.e. encapsidated.
As previously observed [7], protection was not absolute but,
importantly, the di¡erence between the mixed particles con-
taining coreSNwt, or coreSNmut87, was maintained. This
suggests the active nuclease of the coreSNwt protein had al-
ready digested part of the RNA, either in the bacteria or
during work-up.
Because SN activity is Ca2-dependent, we also incubated
the particle preparations with 10 mM CaCl2 before loading
the samples. This pretreatment had no e¡ect on the staining
intensity of wild-type core particles and on the mosaic par-
ticles containing the inactive coreSNmut protein (Fig. 6, lanes 1c and 5c). By contrast, the residual staining of the coreSNwt-
containing material was completely abolished (lane 4c), indi-
cating Ca2-dependent activation of the SN domains. In ad-
dition, the treatment induced a drastic mobility shift speci¢-
cally for the coreSNwt chimera (compare lanes 4a and 4b to
4c in the Coomassie stain). This result is consistent with the
Ca2-induced elimination of the particle-stabilizing interac-
tions between the packaged RNA and the basic C-termini
of the wt-core protein subunits. Together, these data indicate
that the SN domains inside the particle are active and prop-
erly folded, and that they can be activated by exogenous ad-
dition of Ca2-ions.
4. Discussion
In this report, we show that (i) foreign protein domains of
similar size and number to the core protein subunits in the
HBV capsid can be packaged into the particle interior by
fusion to the C-terminal end of the core protein’s assembly
domain; (ii) the foreign domains are, at least in part, properly
folded as shown by enzymatic activity in the dissociated state
as well as inside the particle; (iii) the chimeric protein can co-
assemble with the wild-type core protein; (iv) the SN domains
inside the particle can be activated by exogenously added
Ca2, leading to degradation of the packaged E. coli RNA.
The assembly-competence of the coreSN fusion proteins per
se was demonstrated by their fast sedimentation, and by direct
visualization of abundant particles by negative staining and
by cryo EM. The native agarose gel assay, in this case, could
not be used to prove particle formation. Possibly, the steric
stress induced by the large foreign domains destabilizes the
particles such that they disintegrate under the conditions of
gel electrophoresis, as previously observed with some core
protein point variants [12]. This view is also supported by
the frequently deformed appearance of neat coreSN particles
in negative staining where the sample is treated with heavy
metal salts at low pH, while the particles appeared more reg-
ular under the near-native conditions of cryo EM.
The internal localization of the SN domains is supported by
several lines of evidence. In the EM analysis, the diameter of
the chimeric particles was about equal to that of wild-type
cores; by contrast, coreGFP particles with their surface ex-
posed GFP domains are larger (Fig. 3). In addition, the chi-
meric capsid shells appeared much thicker than those of the
Fig. 6. Ca2-dependent activity of the SN domains in coreSNwt/c1^
183 mosaic particles. Particle preparations from pure proteins wild-
type c1^183 (lanes 1), coreSNwt (lanes 2), coreSNmut87 (lanes 3),
and from coreSNwt and coreSNmut87 co-expressed with wild-type
c1^183 at a 1:4 ratio (lanes 4 and 5) were incubated with PBS bu¡-
er (control), or RNase A, or 10 mM CaCl2 as indicated, then ana-
lyzed in parallel by native agarose gel electrophoresis. Nucleic acids
were visualized by ethidium bromide staining (upper panel), proteins
by Coomassie blue staining (lower panel). M denotes a DNA size
marker. All samples containing wild-type core protein (lanes 1, 4
and 5) but not those consisting of only chimeric proteins (lanes 2
and 3) showed a strong ethidium bromide staining that co-localized
with the bulk of protein. The staining was largely resistant to
RNase A while CaCl2 led to a complete loss of staining of the mo-
saic particles carrying SNwt domains, accompanied by a drastic mo-
bility shift (lane 4a vs. 4c); mosaic particles with SNmut domains
remained una¡ected (lane 5a vs. 5c).
Fig. 7. The HBV capsid as an icosahedral sca¡old for foreign pro-
tein domains. Depending on the junction site, the HBV core protein
can be used to generate particles that either package the heterolo-
gous domains into their interior (left: fusion to the C-terminal end
of the assembly domain) as shown here for SN, or that display the
foreign domains on their surface (right: insertion into the central
c/e1 epitope region), as previously demonstrated for GFP.
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wild-type protein. This has been further con¢rmed in the
meantime by a low resolution three-dimensional reconstruc-
tion that revealed extra mass inside but not on the surface of
the chimeric particles. Independently, the about 20-fold in-
creased nuclease activity upon treatment with partially dena-
turing conditions fully supports an interior location of the SN
domains.
How plausible is it that the lumen of the HBV capsid can
accommodate about 4 MDa of foreign protein mass? The
radius of the inner capsid lumen is around 13 nm [14]. For
a regular sphere, this amounts to a volume of roughly 9000
nm3. The dimensions of native SN are about 4U3U3 nm (D.
Shortle, personal communication), hence the volume of one
subunit corresponds to about 36 nm3, and that of 240 sub-
units to about 8600 nm3. Not considering packing problems,
this estimate suggests that there is indeed su⁄cient space for
all SN domains (but probably not for a similar number of
much larger protein domains).
The ability of the chimeric coreSN protein to co-assemble
with wild-type core protein was demonstrated by co-sedimen-
tation, by native agarose gel electrophoresis and by the uni-
form appearance of the particles by conventional EM. More-
over, the sensitivity of the RNA contained in these particles
toward activation of the SN domains by Ca2-ions (Fig. 6)
demonstrates that the coreSN domains are directed into their
interior.
The results described above have several implications. To-
gether with our recent demonstration that the entire GFP can
be natively displayed on the surface of the HBV capsid [21],
the current study shows that the capsid can be used as a
macromolecular platform to force up to 240 foreign protein
domains into an ordered superstructure, at will either inside,
or on the surface of the icosahedral capsid frame (Fig. 7).
In addition, our data may be relevant to the application of
the HBV capsid as a tool in vaccine development, and as a
target for antiviral therapy. Authentic HBV capsids can act as
T cell-independent antigens because the repetitive display of
identical structural features on the particle surface directly
activates B cells [34]. To exploit this fact for vaccines, heter-
ologous sequences should be inserted into the immuno-dom-
inant c/e1 epitope region rather than at the C-terminal end of
the assembly domain. Our data are consistent with the view
that the low immunogenicity of a number of foreign peptides
attached to the latter site [18] is due to their interior local-
ization in the capsid, at least up to a certain size. Whether
larger foreign domains might be directed to the particle sur-
face remains to be determined. We do not exclude this possi-
bility because the region around aa 150 is part of a £exible
hinge connecting the assembly and the nucleic acid binding
domains [35] ; unfortunately, this region was not visible, or
absent, respectively, in the capsids used for X-ray analysis
[14].
The HBV capsid is also a potential target for therapy [16].
A conceptually powerful strategy is that of ‘capsid-targeted
viral inactivation’ [36] which, by fusion to a viral structural
protein, aims at directing a degradative enzyme speci¢cally
into virus particles. Its principal feasibility has been demon-
strated using the yeast retrotransposon Ty1 [37], and the Mo-
loney murine leukemia virus model system [38,39]. The prop-
erties of the coreSN chimera described in this study suggest it
as an attractive candidate for the application of this strategy
to HBV, and experiments to con¢rm its antiviral activity are
underway.
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